Company
United StatesPublic company, NYSE: CAHCardinal Health, Inc (NYSE: CAH), Houston, TX – FDA Inspections
Inspection records and compliance data for Cardinal Health, Inc in Houston, Texas. 4 FDA inspections on record, 1 Form 483, last inspected February 21, 2026. Publicly traded as NYSE: CAH.
Company Profile
This profile covers Cardinal Health, Inc based in Houston, Texas, United States.
FDA Inspection History
- FDA inspections
- 4
- OAI
- 0
- VAI
- 0
- NAI
- 3
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 0
First inspected September 17, 2012. Last inspected February 21, 2026.
Most cited issue areas
- Equipment1 inspection
- Record quality1 inspection
FDA inspections (4)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| February 21, 2026 | Not classified | Human Drugs · Drug Quality Assurance | 1304424 |
| May 26, 2016 | NAI | Human Drugs · Drug Quality Assurance | 977922 |
| August 18, 2014 | NAI | Human Drugs · Drug Quality Assurance | 892549 |
| September 17, 2012 | NAI | Human Drugs · Drug Quality Assurance | 799530 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Cardinal Health, Inc
Stock ticker
CAH
Exchange
NYSE
Share price
$278.14
Market cap
$64.3B
Price as of
November 13, 2026
FEI Number
3003613908
Address
7849 Almeda Rd, Houston, Texas 77054, United States
Country
United States
ID: 2d5c7072-192f-4c99-b62d-10cac97733a0